REDUCE Haloperidol

In critically ill adults, does haloperidol 1 mg or haloperidol 2 mg given three times a day compared to placebo reduce mortality?
Continue reading »A compendium of critical appraisals in Intensive Care Medicine research and related specialties
In critically ill adults, does haloperidol 1 mg or haloperidol 2 mg given three times a day compared to placebo reduce mortality?
Continue reading »In ventilated, critically ill patients, does the use of dexmedetomidine as the primary sedative agent compared with usual sedative agents effect 90 day mortality?
Continue reading »In delirious adult ICU patients, does the administration of haloperidol or ziprasidone reduce the duration of delirium when compared with placebo?
Continue reading »In critically ill adults, does the administration of ramelteon compared to placebo reduce the length of intensive care stay?
Continue reading »In delirium free critically ill adult patients receiving sedation, does the addition of nocturnal low dose dexmedetomidine prevent delirium and improve sleep?
Continue reading »In mechanically ventilated patients, does the early administration of simvastatin compared to placebo reduce the incidence of brain dysfunction (delirium and / or coma)?
Continue reading »In ventilated patients with sepsis, does a sedation strategy with dexmedetomidine compared with no dexmedetomidine improve mortality and number of ventilator-free days?
Continue reading »In adult ICU patients, does the use dynamic light therapy compared to normal lighting, reduce the incidence and duration of ICU-acquired delirium?
Continue reading »In elderly patients following non-cardiac surgery, does a low dose dexmedetomidine infusion, compared with placebo, decrease the incidence of delirium?
Continue reading »In critically ill patients does early treatment with haloperidol decrease the time that survivors spend in delirium or coma?
Continue reading »